Literature DB >> 8587905

Memory retrieval enhancement by kappa opioid agonist and mu, delta antagonists.

R Y Ilyutchenok1, N I Dubrovina.   

Abstract

The present study sought to identify specific opioid receptor subtypes involved in the modulation of reactivation of amnesic or forgotten memory traces by use of a one-trial inhibitory avoidance training procedures in mice. The effects of naloxone, ICI 174,864 (mu and delta opioid receptor antagonists, respectively) and dynorphin (kappa agonist) were investigated. The results indicated that preretention test administration of naloxone (2 mg/kg) or ICI 174,864 (3 mg/kg) attenuated the amnesia and forgetting as indicated by prolongation of step-through latency. On the other hand, the activation of kappa opioid receptors by dynorphin (1 mg/kg) also showed reactivating effects both after amnesia and forgetting. On the basis of the parallelism of the effects for mu and delta opioid receptor antagonists and kappa agonist, and on the finding that all three opioids demonstrated a different degree of reactivation of amnesic and forgotten memory traces, it was concluded that mu, delta, and kappa opioid receptors contribute to the modulation of amnesia and forgetting by independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8587905     DOI: 10.1016/0091-3057(95)00099-i

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  4 in total

1.  Stress modulation of the memory retrograde-enhancing effects of the awakening drug modafinil in mice.

Authors:  Daniel Béracochéa; Pierrette Liscia; Christophe Tronche; Frédéric Chauveau; Jean-Claude Jouanin; Christophe Piérard
Journal:  Psychopharmacology (Berl)       Date:  2007-10-13       Impact factor: 4.530

2.  Impaired hippocampus-dependent and facilitated striatum-dependent behaviors in mice lacking the δ opioid receptor.

Authors:  Julie Le Merrer; Xavier Rezai; Grégory Scherrer; Jérôme A J Becker; Brigitte L Kieffer
Journal:  Neuropsychopharmacology       Date:  2013-01-04       Impact factor: 7.853

3.  Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS).

Authors:  Diego A Pizzagalli; Moria Smoski; Yuen-Siang Ang; Alexis E Whitton; Gerard Sanacora; Sanjay J Mathew; John Nurnberger; Sarah H Lisanby; Dan V Iosifescu; James W Murrough; Hongqiu Yang; Richard D Weiner; Joseph R Calabrese; Wayne Goodman; William Z Potter; Andrew D Krystal
Journal:  Neuropsychopharmacology       Date:  2020-06-16       Impact factor: 7.853

Review 4.  Neuromodulatory signaling in hippocampus-dependent memory retrieval.

Authors:  Steven A Thomas
Journal:  Hippocampus       Date:  2015-04       Impact factor: 3.753

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.